美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 10 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| NELARABINE |
215037 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2021/11/17
|
2021/11/17
|
ZYDUS PHARMS |
Prescription |
| NELARABINE |
216934 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2022/12/22
|
2022/12/23
|
DR REDDYS |
Prescription |
| NELARABINE |
216038 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2023/01/10
|
2023/01/10
|
MEITHEAL |
Prescription |
| NELARABINE |
214809 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2023/03/03
|
2023/03/03
|
SHORLA |
Prescription |
| NELARABINE |
216346 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2023/04/04
|
2023/04/04
|
AMNEAL |
Prescription |
| NELARABINE |
215057 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2023/06/02
|
2023/06/02
|
NEXUS |
Prescription |
| NELARABINE |
212605 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2024/01/03
|
2024/01/03
|
GLAND PHARMA LTD |
Prescription |
| NELARABINE |
218554 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2024/08/01
|
2024/08/01
|
ALEMBIC |
Prescription |
| NELARABINE |
216510 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2024/09/05
|
2024/09/05
|
XGEN PHARMS |
Prescription |
| NELARABINE |
216948 |
001 |
ANDA |
NELARABINE |
INJECTABLE;INTRAVENOUS |
250MG/50ML (5MG/ML) |
No
|
No
|
2024/09/13
|
2024/09/13
|
MSN |
Prescription |